Freestone Grove Partners’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-918,608
Closed -$125M 680
2025
Q2
$125M Buy
918,608
+827,725
+911% +$109M 0.94% 6
2025
Q1
$12.1M Buy
+90,883
New +$11.6M 0.12% 214

Other funds holding ABT

Freestone Grove Partners's ABT Position: Q3 2025 in Review

Freestone Grove Partners sold out of Abbott (ABT) in Q3 2025, closing a stake of 918,608 shares — an estimated $125M sold.

Freestone Grove Partners first reported a position in ABT in Q1 2025 and held it in 2 quarters. The position peaked at $125M in Q2 2025. 3,172 funds tracked by Wall St. Rank hold ABT as of Q3 2025.

  • Freestone Grove Partners reported no remaining Abbott position as of Q3 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 918,608 Abbott shares in Q3 2025, an estimated $125M.
  • Freestone Grove Partners first reported a position in Abbott in Q1 2025 and held it in 2 quarters.
  • Freestone Grove Partners's Abbott position peaked at $125M in Q2 2025.
  • 3,172 funds tracked by Wall St. Rank held Abbott as of Q3 2025.

Based on Freestone Grove Partners's 13F filing for Q3 2025, filed 14 Nov 2025.